In the absence of hard evidence, US medical associations and the National Institutes of Health have not recommended remdesivir for treatment of Covid-19 so far
from Latest News https://ift.tt/2Y4YEtq
https://ift.tt/eA8V8J https://ift.tt/2LUVdkd
Home
Business
Business News
Business Standard
Latest News
Gilead's Covid-19 cure trial may yield results ahead of schedule: Report
0 comments: